An analysis of 13,008 cancer patients with concurrent type 2 diabetes showed that those who took metformin attained better overall survival compared with those who took other diabetes medications. However, it is still unclear whether metformin may help modulate results in such patients, researchers wrote in the journal The Oncologist.

Related Summaries